A post hoc analysis of linaclotide in pediatric patients with functional constipation and neurodevelopmental disorders
CONCLUSIONS: In children with FC and comorbid NDD, linaclotide 72 µg once daily was associated with improved constipation outcomes, high adherence, and a well-tolerated safety profile, similar to that seen…
Suggested reading